The global gastrointestinal diagnostics market size is expected to reach USD 6.87 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.58% from 2022 to 2030. Rising awareness about gastrointestinal disorders and a surge in gastrointestinal disorder testing are the major factors driving the market. Moreover, technological advancements in gastrointestinal infection testing are expected to cater to the market demand. For instance, in May 2022, QIAGEN launched QIAstat-Dx Rise, which is capable of providing results in a span of one hour for multiple diseases.
Gastrointestinal Diagnostics Market Report Highlights
· On the basis of test type, the endoscopy segment held the largest share in 2021 owing to rising demand for minimally invasive procedures
· Based on technology, the PCR accounted for the second-largest share in 2021 due to the availability of a robust product portfolio and rising product launches
· The infection application segment held the largest share in 2021 owing to the higher incidence of GI infections and the surge in awareness
· On the basis of test location, the central laboratories segment held the largest share in 2021. The point-of-care segment is anticipated to register the fastest growth rate throughout the forecast period
· Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the rising investments by market players and increasing research activities in the region
Gain deeper insights on the market and receive your free copy with TOC now @: Gastrointestinal Diagnostics Market Report
The increasing trend of a sedentary lifestyle, lack of exercise, unhealthy eating habits, and a higher prevalence of obesity are anticipated to fuel GI diagnostics market growth. According to the CDC, the prevalence of obesity among people in the U.S. is between 30-40%. States such as Alabama, Alaska, and Arizona have the highest prevalence of obesity in the U.S. Obesity is associated with GI diseases such as gastroesophageal reflux disease, diarrhea, gastric cancer, and others. Hence, it is expected to impetus market growth.
Technological advancements associated with gastrointestinal diagnostics for early diagnosis and efficient testing are expected to augment market growth during the forecast period. For instance, in March 2022, Luminex Corporation obtained a CE mark for its NxTAGxMAP GI Pathogen Panel. This test is a detailed multiplex test that detects nucleic acids from the 16 most clinically relevant viral, parasitic, and bacterial pathogens in stool samples. Moreover, the test is capable of providing results on the same day and can run 96 samples at a time.
Moreover, the presence of organizations involved in increasing awareness regarding gastrointestinal disorders is expected to facilitate market expansion. For instance, organizations such as the Gastrointestinal Society (Canadian Society of Intestinal Research) and the International Foundation for Gastrointestinal Disorders are actively involved in promoting gastrointestinal health and broadening the understanding of GI disorders, thereby augmenting market growth.
Furthermore, various strategic initiatives undertaken by market players to strengthen their product portfolio and expand global footprints are likely to provide lucrative growth opportunities for the market. For instance, in November 2021, The Life Raft Group and Bayer Pharmaceuticals announced a research collaboration for broadening access to genomic testing for GI stromal tumor patients. The aim of this collaboration is to advance precision medicine and improve genetic testing to identify patients in the U.S.
In addition, in June 2021, Prometheus Laboratories, Inc. announced an agreement with MultiPlan for accessing specialized gastrointestinal testing. Prometheus offered its breakthrough testing solutions to improve the outcome of GI disorders. This agreement has allowed the testing service of Prometheus to reach the maximum number of customers.
For More Details or Sample Copy please visit link @: https://www.grandviewresearch.com/industry-analysis/gastrointestinal-diagnostics-market-report/request/rs1
List of Key Players in Gastrointestinal Diagnostics Market
· BIOMERIEUX
· F. Hoffmann-La Roche Ltd.
· Abbott
· Beckman Coulter, Inc.
· DiaSorin S.p.A
· Siemens Healthineers AG
· QIAGEN
· Meridian Bioscience
· Hologic, Inc.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/checkout/select-license/gastrointestinal-diagnostics-market-report
Segmented the global gastrointestinal diagnostics market based on test type, technology, application, test location, and region.
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3 Gastrointestinal Diagnostics Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increase in prevalence of Gastrointestinal disorders
3.2.1.2 Technological advancements pertaining to GI diagnostics
3.2.2 Market restraint analysis
3.2.2.1 Presence of stringent rules and regulations for GI diagnostic procedures
3.3 Penetration & Growth Prospect Mapping
3.4 Gastrointestinal Diagnostics: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis
Chapter 4 Gastrointestinal DiagnosticsMarket Segment Analysis, By Test Type, 2018-2030 (USD Million)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2021& 2030
4.3 Segment Dashboard
4.4 Global Gastrointestinal DiagnosticsMarket, by Test Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Endoscopy
4.5.1.1 Endoscopy market estimates and forecasts, 2018-2030 (USD Million)
4.5.2 Blood Test
4.5.2.1 Blood test market estimates and forecasts, 2018-2030 (USD Million)
4.5.3 H. Pylori Test
4.5.3.1 H.pylori testmarket estimates and forecasts, 2018-2030 (USD Million)
4.5.4 Calprotectin Test
4.5.4.1 Calprotectin test market estimates and forecasts, 2018-2030 (USD Million)
4.5.5 Immunoglobulin A Test
4.5.5.1 Immunoglobulin A test market estimates and forecasts, 2018-2030 (USD Million)
4.5.6 Others
4.5.6.1 Others market estimates and forecasts, 2018-2030 (USD Million)
Chapter 5 Gastrointestinal Diagnostics Market Segment Analysis, By Technology2018-2030 (USD Million)
5.1 Definition and Scope
5.2 Technology Market Share Analysis, 2021& 2030
5.3 Segment Dashboard
5.4 Global Gastrointestinal Diagnostics Market, by Technology, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 PCR
5.5.1.1 PCR market estimates and forecasts, 2018-2030 (USD Million)
5.5.2 Microbiology
5.5.2.1 Microbiology market estimates and forecasts, 2018-2030 (USD Million)
5.5.3 ELISA
5.5.3.1 ELISA market estimates and forecasts, 2018-2030 (USD Million)
5.5.4 Others
5.5.4.1 Others market estimates and forecasts, 2018-2030 (USD Million)
Chapter 6 Gastrointestinal Diagnostics Market Segment Analysis, By Application, 2018-2030 (USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2021& 2030
6.3 Segment Dashboard
6.4 Global Gastrointestinal Diagnostics Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Infection
6.5.1.1 Infection market estimates and forecasts, 2018-2030 (USD Million)
6.5.2 Inflammatory Bowel Disease
6.5.2.1 Inflammatory bowel disease market estimates and forecasts, 2018-2030 (USD Million)
6.5.3 Gastroesophageal Reflux Disease (GERD)
6.5.3.1 Gastroesophageal Reflux Disease market estimates and forecasts, 2018-2030 (USD Million)
6.5.4 Cancer
6.5.4.1 Cancer market estimates and forecasts, 2018-2030 (USD Million)
6.5.5 Others
6.5.5.1 Others market estimates and forecasts, 2018-2030 (USD Million)
Chapter 7 Gastrointestinal Diagnostics Market Segment Analysis, By Test Location, 2018-2030 (USD Million)
7.1 Definition and Scope
7.2 Test Location Market Share Analysis, 2021& 2030
7.3 Segment Dashboard
7.4 Global Gastrointestinal Diagnostics Market, by Test Location, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Central Laboratories
7.5.1.1 Central laboratories market estimates and forecasts, 2018-2030 (USD Million)
7.5.2 Point-of-Care
7.5.2.1 Point-of-care market estimates and forecasts, 2018-2030 (USD Million)
There are many startups looking for ways to make healthcare more affordable and accessible to everyone, but how does this affect small businesses?
With the help of any customized software development company, you can implement these techniques in your healthcare solution.This blog post will explore some of the most significant technological advances in health care today and discuss their implications on your business.1) Augmented RealityIn 2014, Google Glass proved to be a dud as a consumer product.
But healthcare is one of those industries that could truly benefit from an AR device.
For example, surgeons could use it to assist in delicate surgeries or other procedures where a high level of precision is required—and other doctors could use it for education.2) Artificial IntelligenceArtificial intelligence, also known as AI, is a concept that’s been around for decades.
In recent years, however, a number of studies have surfaced suggesting that AI can be a tremendous benefit to our healthcare system.
Here are three ways that businesses and research organizations are using artificial intelligence in medicine3) Genome sequencingThe idea of sequencing genomes dates back to 1984, when a graduate student named J. Craig Venter published a paper in Science describing his research on building genetic maps of organisms.
Initially, I go with What is Enterprise Content Management?What is Enterprise Content Management (ECM)?Do you have any idea What is enterprise content management meaning?
Simply put, ECM is the framework for automated digital document management: the collection, storage, management, organization, and distribution of documents and files so that they are accessible to the appropriate people and processes in your systems.Replace your messy, expensive paper workflow with an advanced digitized system that will help you improve patient care, increase compliance, and lower costs.
Our Enterprise Content Management (ECM) solution for healthcare provides advanced analysis, consulting, software, implementation, training, and support.Simplify your transition to digital health information management.When you rely on manual procedures, maintaining health information can be very difficult, time-consuming, and prone to errors.
But with enterprise content management, you get a digital system that can streamline data management throughout your organization.Our health professionals do a pre-analysis before designing a solution.
You can support effective care delivery, compliance, billing, and communication:Easily manages information from creation through deletion in an integrated system.Electronic Maintains a convenient central repository that feeds your electronic health records (EHR).Business Automates workflows and work queues based on your business rules.Overcome information management challengesReduce cost and complexity while increasing efficiency.Think about all the data formats you generate in the clinical, financial, human resources, shipping/receiving, and other fields.
Maintaining structured data such as lab results, patient admission information, and monthly income reports is not easy when everything is on paper.Our ECM experts analyze your data flow and then apply LEAN and Stigma techniques to validate your business processes, eliminate inefficiencies, and identify potential mitigation measures.
